Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KROMEK GROUP PLC Director's Dealing 2017

Oct 10, 2017

7753_dirs_2017-10-10_662d98e1-02b6-48dc-b758-37574236374e.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1743T

Kromek Group PLC

10 October 2017

10 October 2017

Kromek Group plc

("Kromek" or the "Company" or the "Group")

Director/PDMR Shareholdings

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announces that it has received notification of the following purchases by Directors of Ordinary Shares of 1 pence each ("Ordinary Shares") in the Company:

Director Position Date of transaction Number of Ordinary Shares purchased in the transaction Price at which Ordinary Shares were purchased Number of Ordinary Shares held post transaction Percentage of share capital held post transaction
Derek Bulmer Chief Financial Officer 9 October 2017 36,066 24.4p 100,000 0.04%
Lawrence Kinet Non-executive Director 4 October 2017 50,000 23.5p 250,000 0.10%

Enquiries:

Kromek Group plc +44 (0)1740 626 060
Arnab Basu, CEO

Derek Bulmer, CFO
Cenkos Securities plc +44 (0)20 7397 8900
Bobbie Hilliam (NOMAD)

Julian Morse (Sales)
Luther Pendragon Ltd +44 (0)20 7618 9100
Harry Chathli, Claire Norbury, Alexis Gore

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Derek Bulmer

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

N/a

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
24.4p 36,066

d)

Aggregated information

- Aggregated volume

- Price

36,066 Ordinary Shares

24.4p per Ordinary Share

e)

Date of the transaction

9 October 2017

f)

Place of the transaction

London Stock Exchange

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Lawrence Kinet

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

N/a

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
23.5p 50,000

d)

Aggregated information

- Aggregated volume

- Price

50,000 Ordinary Shares

23.5p per Ordinary Share

e)

Date of the transaction

4 October 2017

f)

Place of the transaction

London Stock Exchange

About Kromek Group plc

Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKKDQFBDKPKD